20 juni
2026

Realtid

Webcast with Teleconference, Q3 / 2024

Pressmeddelande

Pressmeddelande

Nitro Games to host a Webcast on Monday 28 October 2024 09:30 Swedish time.

Nitro Games Oyj Interim report for January – September 2024 will be released on Monday 28 October 2024. The Company will do a presentation after the release of the report. Participants can join this presentation via a Webcast. Participants can send questions to the presenters via email below.

28 October 2024 09:30 (Europe/Stockholm)

Details of event: https://financialhearings.com/event/49792

Language: English

Activity: Webcast

Webcast: https://ir.financialhearings.com/nitro-games-q3-report-2024/register

Questions via email: info@nitrogames.com

For more information:

Jussi Tähtinen, CEO & Co-Founder

Phone: +358 44 388 1071

Email: jussi@nitrogames.com


Nitro Games in brief:

Nitro Games is a mobile game developer and publisher. Nitro Games team is a multinational group of mobile gaming professionals that has the expertise from development to publishing to live-operations. The Company focuses on producing high quality mobile games mostly for the mid-core audience. Nitro Games is specialized in the category of shooter games. With Nitro Games’ powerful NG Platform and the NG MVP process, the Company is able to carry out market validation with its games during development. Nitro Games has developed several games such as Autogun Heroes, NERF: Superblast, Lootland, Heroes of Warland, Medals of War, Raids of Glory. The company offers its services also to selected customers and has developed several successful projects to leading mobile gaming companies. 

Nitro Games’ shares are listed on Nasdaq First North Growth Market with the ticker NITRO. The Certified Adviser is FNCA Sweden AB, info@fnca.se.

www.nitrogames.com

Finnish Business ID: FI21348196

Senaste lediga jobben

Mest läst i kategorin

Utvalda pressmeddelanden

Burger King Mobilia invigning i Malmö invigs efter omfattande renovering – Burger King firar med exklusiva erbjudanden

12 juni 2026
Utvalda pressmeddelanden

Anocca har behandlat de första patienterna med TCR-T-cellterapi riktad mot muterat KRAS vid bukspottkörtelcancer

11 juni 2026
Utvalda pressmeddelanden

Årsstämma har hållits i OssDsign AB

10 juni 2026